China GLP-1RA market is thriving with Eli Lilly’s recent NMPA approval, surpassing Novo in the oral medication sector.
pharma
Trade Margins on Anti-Cancer Drugs: Clear Price Cuts Ahead
Trade margins on anti-cancer drugs are now capped, leading to significant price reductions for patients.
Methylprednisolone Injection approval: Safe and Proven USFDA Success
Methylprednisolone Injection approval has significant market potential after USFDA clearance. Discover the implications for Gland Pharma.
Sun Pharma shares fall: Q2 profit plunges 36%
Sun Pharma shares fall as Q2 profit plunges 36%, impacting brokerages’ target prices despite their bullish outlook.
Macular Degeneration Drug Approval: Proven Steps to Success
Macular degeneration drug approval is a significant milestone for Olix, enhancing its global licensing strategy.
Expired Covid-era approvals: Are they the worst mistake?
Expired Covid-era approvals raise serious concerns about safety and efficacy. Discover the implications of these approvals and what they mean for public health.
Export NOC for r-DNA drugs: Is it the Best Move?
Export NOC for r-DNA drugs is a significant change in regulations that could benefit the pharmaceutical industry.
Are Drug Price Caps the Best Solution for Life-Saving Medicines?
Drug price caps are crucial for ensuring access to life-saving medicines. Discover their impact now.
GLP-1 Obesity Drug: Best Proven Solution by Hanmi Pharmaceutical
GLP-1 obesity drug is now approved in South Korea, offering a proven solution for weight management by Hanmi Pharmaceutical.
Sterile injectables market: Proven growth with Biodeal’s acquisition
Sterile injectables market sees growth as Biodeal Pharma acquires Biological E facility to expand its offerings.